Are Thirumalai Chemicals Ltd latest results good or bad?

1 hour ago
share
Share Via
Thirumalai Chemicals Ltd's latest results show strong revenue growth of 28.86% sequentially, but the company still faces challenges with a net loss of ₹43.67 crores and high debt levels, indicating ongoing financial difficulties despite operational recovery. Investors should watch for future performance trends.
Thirumalai Chemicals Ltd's latest financial results for Q1 FY27 present a complex picture of operational recovery juxtaposed with ongoing financial challenges. The company reported a revenue of ₹546.67 crores, marking a significant sequential growth of 28.86% from ₹424.25 crores in Q4 FY26, and a year-on-year increase of 21.47%. This rebound in top-line performance is attributed to improved demand and capacity utilization in its phthalic anhydride and food acids segments, suggesting a potential recovery in market conditions.
However, the bottom line remains a concern, with the company incurring a net loss of ₹43.67 crores, which, while slightly better than the previous quarter's loss, reflects a worsening situation compared to the same quarter last year, where losses were also substantial. The operating margin improved to 5.96%, a notable recovery from the previous quarter's 1.45%, yet it remains low relative to historical performance, indicating that profitability is still elusive. The financial strain is exacerbated by a significant interest burden, which surged to ₹51.97 crores, consuming the entirety of the operating profit and raising questions about the company's financial sustainability. The debt-to-equity ratio stands at 1.22, highlighting the elevated debt levels of ₹1,565.84 crores, which poses a risk to the company's financial flexibility and ability to service its obligations. Overall, while Thirumalai Chemicals has made strides in revenue recovery, the persistent losses, high interest expenses, and significant debt burden underscore the challenges it faces. The company saw an adjustment in its evaluation, reflecting the ongoing operational and financial complexities. Investors should closely monitor future performance for signs of sustained improvement or further deterioration in these critical areas.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News